Recent advances in understanding the etiology and pathogenesis of pediatric germ cell tumors

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 4, 2014, Pages 263-270

  Mosbech, Christiane H ^a   Rechnitzer, Catherine ^a   Brok, Jesper S ^a   Rajpert De Meyts, Ewa ^a   Hoei Hansen, Christina E ^a,b  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

Author keywords

children; germ cell tumor; pathogenesis; primordial germ cell

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR PROTEIN;

ARTICLE; CANCER CLASSIFICATION; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; DEVELOPMENTAL STAGE; DNA POLYMORPHISM; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GERM CELL TUMOR; HETEROZYGOSITY LOSS; HUMAN; MOLECULAR PATHOLOGY; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR GENE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENITAL NEOPLASMS, FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; INFANT; MALE; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; SACROCOCCYGEAL REGION;

EID: 84899923294     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000125     Document Type: Article

References (61)

1. Pinkerton CR. Malignant germ cell tumours in childhood. Eur J Cancer. 1997;33:895-901.
2. Horton Z, Schlatter M, Schultz S. Pediatric germ cell tumors. Surg Oncol. 2007;16:205-213.
3. Imbach P, Kühne T, Arceci RJ. Pediatric Oncology: A Comprehensive Guide. 2nd ed. Berlin: Springer; 2011.
4. Schneider DT, Calaminus G, Koch S, et al. Epidemiologic analysis of 1442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer. 2004;42:169-175.
5. Gobel U, Calaminus G, Schneider DT, et al. Management of germ cell tumors in children: approaches to cure. Onkologie. 2002;25:14-22.
6. Mann JR, Raafat F, Robinson K, et al. The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol. 2000;18:3809-3818.
7. Kiltie AE, Gattamaneni HR. Survival and quality of life of paediatric intracranial germ cell tumour patients treated at the Christie Hospital, 1972-1993. Med Pediatr Oncol. 1995; 25:450-456.
8. Jeyapalan JN, Noor DA, Lee SH, et al. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance. Br J Cancer. 2011;105: 575-585.
9. Pussegoda K, Ross CJ, Visscher H, et al. Replication of TPMT and ABCC3 genetic variants highly associated with cisplatininduced hearing loss in children. Clin Pharmacol Ther. 2013; 94:243-251.
10. Veltman IM, Schepens MT, Looijenga LH, et al. Germ cell tumours in neonates and infants: a distinct subgroup? APMIS. 2003;111:152-160; discussion 160.
11. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210-222.
12. Wylie CC. The biology of primordial germ cells. Eur Urol. 1993;23:62-66.
13. Hajkova P, Erhardt S, Lane N, et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev. 2002;117:15-23.
14. Eini R, Dorssers LC, Looijenga LH. Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. Int J Dev Biol. 2013;57:319-332.
15. Teilum G. Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called "embryonal carcinoma" of the ovary. Acta Pathol Microbiol Scand. 1965;64:407-429.
16. Rescorla FJ. Pediatric germ cell tumors. Semin Pediatr Surg. 2012;21:51-60.
17. Hoei-Hansen CE, Sehested A, Juhler M, et al. New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol. 2006;209:25-33.
18. Jorgensen N, Muller J, Giwercman A, et al. DNA content and expression of tumour markers in germ cells adjacent to germ cell tumours in childhood: probably a different origin for infantile and adolescent germ cell tumours. J Pathol. 1995;176:269-278.
19. Harms D, Zahn S, Gobel U, et al. Pathology and molecular biology of teratomas in childhood and adolescence. Klin Padiatr. 2006;218:296-302.
20. Echevarria ME, Fangusaro J, Goldman S. Pediatric central nervous system germ cell tumors: a review. Oncologist. 2008;13:690-699.
21. Borer JG, Tan PE, Diamond DA. The spectrum of Sertoli cell tumors in children. Urol Clin North Am. 2000;27:529-541.
22. Lahdenne P, Pitkanen S, Rajantie J, et al. Tumor markers CA 125 and CA 19-9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors. Pediatr Res. 1995;38:797-801.
23. Talebagha S, Rizk C, Elawabdeh N, et al. Usefulness of OCT4/3 immunostain in pediatric malignant germ cell tumors. Fetal Pediatr Pathol. 2013;32:82-87.
24. Ho DM, Liu HC. Primary intracranial germ cell tumor. Pathologic study of 51 patients. Cancer. 1992;70:1577-1584.
25. Siltanen S, Anttonen M, Heikkila P, et al. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors. Am J Pathol. 1999;155:1823-1829.
26. Perlman EJ, Hawkins EP. Pediatric germ cell tumors: protocol update for pathologists. Pediatr Dev Pathol. 1998;1: 328-335.
27. Skakkebaek NE. Possible carcinoma-in-situ of the testis. Lancet. 1972;2:516-517.
28. Hoei-Hansen CE, Kraggerud SM, Abeler VM, et al. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer. 2007;6:12.
29. Chou PM, Barquin N, Guinan P, et al. Differential expression of p53, c-kit, and CD34 in prepubertal and postpubertal testicular germ cell tumors. Cancer. 1997;79:2430-2434.
30. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244-2250.
31. Rajpert-De Meyts E, Hanstein R, Jorgensen N, et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod. 2004;19:1338-1344.
32. Hoei-Hansen CE, Almstrup K, Nielsen JE, et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology. 2005;47:48-56.
33. Sonne SB, Perrett RM, Nielsen JE, et al. Analysis of SOX2 expression in developing human testis and germ cell neoplasia. Int J Dev Biol. 2010;54:755-760.
34. Perrett RM, Turnpenny L, Eckert JJ, et al. The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture. Biol Reprod. 2008;78:852-858.
35. Schafer S, Anschlag J, Nettersheim D, et al. The role of BLIMP1 and its putative downstream target TFAP2C in germ cell development and germ cell tumours. Int J Androl. 2011;34:e152-e158.
36. Hoei-Hansen CE, Nielsen JE, Almstrup K, et al. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res. 2004;10:8521-8530.
37. Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009;33:1065-1077.
38. Salonen J, Rajpert-De Meyts E, Mannisto S, et al. Differential developmental expression of transcription factors GATA-4 and GATA-6, their cofactor FOG-2 and downstream target genes in testicular carcinoma in situ and germ cell tumors. Eur J Endocrinol. 2010;162:625-631.
39. Alagaratnam S, Lind GE, Kraggerud SM, et al. The testicular germ cell tumour transcriptome. Int J Androl. 2011;34:e133-e150.
40. Palmer RD, Barbosa-Morais NL, Gooding EL, et al. Pediatric malignant germ cell tumors show characteristic transcriptome profiles. Cancer Res. 2008;68:4239-4247.
41. Fritsch MK, Schneider DT, Schuster AE, et al. Activation of Wnt/beta-catenin signaling in distinct histologic subtypes of human germ cell tumors. Pediatr Dev Pathol. 2006;9:115-131.
42. Fustino N, Rakheja D, Ateek CS, et al. Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours. Int J Androl. 2011;34:e218-e233.
43. Murray MJ, Saini HK, van Dongen S, et al. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer. 2010;9:290.
44. Wang HW, Wu YH, Hsieh JY, et al. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics. 2010;11:132.
45. Murray MJ, Saini HK, Siegler CA, et al. LIN28 expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels. Cancer Res. 2013;73:4872-4884.
46. Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr. 2001;213:204-211.
47. Bussey KJ, Lawce HJ, Olson SB, et al. Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences-a Children's Cancer Group study. Genes Chromosomes Cancer. 1999;25:134-146.
48. Palmer RD, Foster NA, Vowler SL, et al. Malignant germ cell tumours of childhood: new associations of genomic imbalance. Br J Cancer. 2007;96:667-676.
49. Zahn S, Sievers S, Alemazkour K, et al. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis. Genes Chromosomes Cancer. 2006;45:995-1006.
50. Okpanyi V, Schneider DT, Zahn S, et al. Analysis of the adenomatous polyposis coli (APC) gene in childhood and adolescent germ cell tumors. Pediatr Blood Cancer. 2011;56: 384-391.
51. Rapley EA, Turnbull C, Al Olama AA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet. 2009;41:807-810.
52. Kanetsky PA, Mitra N, Vardhanabhuti S, et al. Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet. 2009;41:811-815.
53. Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010;42:604-607.
54. Poynter JN, Hooten AJ, Frazier AL, et al. Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors. Genes Chromosomes Cancer. 2012;51:266-271.
55. Schneider DT, Schuster AE, Fritsch MK, et al. Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res. 2001;61:7268-7276.
56. Sievers S, Alemazkour K, Zahn S, et al. IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer. 2005;44:256-264.
57. Bussey KJ, Lawce HJ, Himoe E, et al. SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development. Genes Chromosomes Cancer. 2001;32: 342-352.
58. Hoffner L, Deka R, Chakravarti A, et al. Cytogenetics and origins of pediatric germ cell tumors. Cancer Genet Cytogenet. 1994;74:54-58.
59. Visfeldt J, Jorgensen N, Muller J, et al. Testicular germ cell tumours of childhood in Denmark, 1943-1989: incidence and evaluation of histology using immunohistochemical techniques. J Pathol. 1994;174:39-47.
60. Jorgensen N, Giwercman A, Muller J, et al. Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells. Histopathology. 1993;22:373-378.
61. Honecker F, Stoop H, de Krijger RR, et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol. 2004;203: 849-857.